procainamide has been researched along with Malignant Melanoma in 2 studies
Procainamide: A class Ia antiarrhythmic drug that is structurally-related to PROCAINE.
procainamide : A benzamide that is 4-aminobenzamide substituted on the amide N by a 2-(diethylamino)ethyl group. It is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Malignant melanoma has an aggressive nature and a high metastatic propensity resulting in the highest mortality rate of any skin cancer." | 1.91 | Synthesis and evaluation of ( Kim, DY; Kwon, SY; Min, JJ; Pyo, A; Song, B; Yun, M, 2023) |
| " The toxicity of these compounds against hepatoma cells (MH3924A) and, to a lesser extent, against mouse fibroblast (NIH 3T3) and cervix carcinoma (HeLa) cells was also enhanced, but they were not as toxic as dacarbazine (HeLa)." | 1.32 | Alkylating benzamides with melanoma cytotoxicity. ( Bauder-Wüst, U; Eisenhut, M; Haberkorn, U; Mier, W; Mohammed, A; Schönsiegel, F; Wolf, M, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pyo, A | 1 |
| Yun, M | 1 |
| Song, B | 1 |
| Kwon, SY | 1 |
| Min, JJ | 1 |
| Kim, DY | 1 |
| Wolf, M | 1 |
| Bauder-Wüst, U | 1 |
| Mohammed, A | 1 |
| Schönsiegel, F | 1 |
| Mier, W | 1 |
| Haberkorn, U | 1 |
| Eisenhut, M | 1 |
2 other studies available for procainamide and Malignant Melanoma
| Article | Year |
|---|---|
Synthesis and evaluation of
Topics: Animals; Cell Line, Tumor; Fluorine Radioisotopes; Humans; Melanoma; Melanoma, Cutaneous Malignant; | 2023 |
Alkylating benzamides with melanoma cytotoxicity.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Benzamides; Cell Line, Tumor; Cel | 2004 |